Drugs Made In America Acquisition DMIIR
NASDAQ DMIIR
$0.07 -0.01 (-7.04%)
As of: Sep 2, 2026 · 12:48 PM EDT

Drugs Made In America Acquisition (DMIIR) Retained Earnings (2024 - 2026)

Drugs Made In America Acquisition (DMIIR) posted quarterly Retained Earnings of -$17.8 million for Q4 2025, down 11616.53% year-over-year from N/an in Q4 2024, and down 2.86% quarter-over-quarter from -$17.3 million in Q3 2025.

Analysis

Drugs Made In America Acquisition (DMIIR) Retained Earnings (2024 - 2026) Analysis & Trends

Drugs Made In America Acquisition (DMIIR) has reported Retained Earnings for 2 consecutive years, with -$17.8 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Retained Earnings fell 11616.53% year-over-year to -$17.8 million; the TTM figure through Dec 2025 stood at -$17.8 million (down 11616.53% YoY), while the FY2025 annual figure was -$17.8 million, down 11616.53% from the prior year.
  • Retained Earnings fell to -$17.8 million in Q4 2025 per DMIIR's latest filing, from -$17.3 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$151719.0 in Q4 2024 and bottomed at -$17.8 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Cluster Group Holdings 8.00 Bn 8.00 Bn - -7.68 Mn
2 Agriculture & Natural Solutions Acquisition 853.42 Mn 853.17 Mn - -34.15 Mn
3 K&F Growth Acquisition 836.15 Mn 836.15 Mn - -9.85 Mn
4 Armada Acquisition 666.23 Mn 666.18 Mn - -14.53 Mn
5 Pioneer Acquisition I 652.74 Mn 652.27 Mn - -11.79 Mn
6 Oxley Bridge Acquisition 652.11 Mn 652.11 Mn - -11.21 Mn
7 Titan Acquisition 651.43 Mn 941.85 Mn - -14.14 Mn
8 GSR IV Acquisition 622.22 Mn 622.22 Mn - -7.94 Mn
9 Launch One Acquisition 618.70 Mn 618.70 Mn - -12.62 Mn
10 Drugs Made In America Acquisition 5.10 Mn 5.10 Mn - -17.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.93 Mn
Dec 31, 2025 -17.78 Mn
Sep 30, 2025 -17.28 Mn
Dec 31, 2024 -151,719.00